The impact of COVID-19 on the heart and cardiovascular system is being evaluated in a new clinic for post-COVID patients to monitor and manage their cardiac recovery.
News | Coronavirus (COVID-19) | November 10, 2020
November 10, 2020 — The Smidt Heart Institute at Cedars-Sinai Hospital in Los Angeles has established a specialized...
NIH trial, the Outcomes Related to COVID-19 treated with Hydroxychloroquine among Inpatients with symptomatic Disease (ORCHID), showed no difference in deaths between placebo and hydroxychloroquine. Getty Images
News | Coronavirus (COVID-19) | November 09, 2020 | Dave Fornell, Editor
November 9, 2020 — A National Institutes of Health (NIH) clinical trial evaluating the safety and effectiveness of...
SCCT Releases New Guidelines for Cardiology and Radiology Trainees in Cardiovascular CT
News | CT Angiography (CTA) | November 09, 2020
November 6, 2020 — The Society of Cardiovascular Computed Tomography (SCCT) has released a new training guideline,...
An example of radiation dose tracking software from Imalogix showing data on cath lab angiography cases at RSNA 2019. Photo by Dave Fornell

An example of radiation dose tracking software from Imalogix showing data on cath lab angiography cases. Photo by Dave Fornell

Feature | Radiation Dose Management | November 04, 2020 | Dave Fornell, Editor
More than a decade ago, there was an alarming, rapid rise in ionizing radiation exposure in the U.S. population that...
The U.S. Food and Drug Administration (FDA) has cleared the Boston Scientific Ranger Drug-coated Balloon, developed for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).  
News | Drug-Eluting Balloons | November 03, 2020
November 3, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the Boston Scientific Ranger Drug-coated...
News | Robotic Systems | November 03, 2020
November 3, 2020 – Robocath, a company commercializing cardiovascular cath lab robotic systems, announced creation of...
The American Heart Association, AHA, late-breaking sessions, trials, studies. #AHA #AHA20 #AHA2020
Feature | AHA | November 20, 2020 | Dave Fornell, Editor
Here is a list of the American Heart Association (AHA) late-breaking clinical trial presentations at the 2020 Virtual...
Two of the top preforming pieces of content in October was the FDA clearance for the first indication for shortened DAPT for Medtronic's Resolute Onyx Drug Eluting Stent. A virtual tour of the new robotic electrophysiology lab at Banner Health led by Pete Weiss, M.D., also was among the most popular cardiology technology content.

Two of the top preforming pieces of content in October was the FDA clearance for the first indication for shortened DAPT for Medtronic's Resolute Onyx Drug Eluting Stent. A virtual tour of the new robotic electrophysiology lab at Banner Health led by Pete Weiss, M.D., also was among the most popular cardiology technology content.

Feature | November 02, 2020
November 2, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
Angiography with a co-registered view of pressure drops according iFR readings in a coronary vessel. The DEFINE PCI study showed patients had improved outcomes and less recurrent chest pain at one year using iFR physiologic measurements combined with landmarks shown on angiographic imaging to better guide therapy. Image by Philips Healthcare. #TCT #TCT2020 #TCTconnect

Angiography with a co-registered view of pressure drops according iFR readings in a coronary vessel. The DEFINE PCI study showed patients had improved outcomes and less recurrent chest pain at one year using iFR physiologic measurements combined with landmarks shown on angiographic imaging to better guide therapy. Image by Philips Healthcare

Feature | FFR Technologies | October 30, 2020 | Dave Fornell, Editor
Fractional flow reserve (FFR) is considered the gold standard measure whether a coronary lesions needs a percutaneous...
Some of the device technologies discussed in the TCT 2020 late-breaking trial sessions. Top left, the  Medtronic Resolute Onyx stent was the first stent to receive FDA clearance for short duration dual-antiplatelet therapy, which was a big topic and subject of several sessions. Lower left, the Keystone TriGuard 3 TAVR embolic protection device did not demonstrate superiority over TAVR without use of embolic protection. Top right, the Abbott MitraClip. Acurate neo TAVR valve. #TCTconnect #TCT2020

Some of the device technologies discussed in the TCT 2020 late-breaking trial sessions. Top left, the Medtronic Resolute Onyx stent was the first stent to receive FDA clearance for short duration dual-antiplatelet therapy, which was a big topic and subject of several sessions. Lower left, the Keystone TriGuard 3 TAVR embolic protection device did not demonstrate superiority over TAVR without use of embolic protection. Top right, the Abbott MitraClip was the subject of two studies, including use to aid heart transplant patients. Bottom right, the Boston Scientific Acurate neo TAVR valve performed below the Sapien 3 and CoreValve Evolut.

Feature | TCT | October 29, 2020 | Dave Fornell, Editor
Here are some of the key takeaways from the late-breaking interventional cardiology and structural heart trials...
This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe.

This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe. 

Feature | Magnetic Resonance Imaging (MRI) | October 29, 2020
October 29, 2020 — Contrast agents used to improve views of the heart on magnetic resonance imaging (MRI) carry a very...
The Watchman FLX will be tested in the CHAMPION-AF trial looks at next-generation transcatheter LAA device as treatment alternative to NOACs for broader population of patients with non-valvular atrial fibrillation.
News | Atrial Fibrillation | October 29, 2020
Oct. 29, 2020 — Boston Scientific initiated the CHAMPION-AF clinical trial to evaluate the safety and efficacy of the...
A sonographer at Northwestern Memorial Hospital using the Caption Health AI to optimize ultrasound imaging. Northwestern Memorial Hospital in Chicago is the first in U.S. to adopt Caption AI (artificial intelligence) to improve ultrasound imaging in emergency department, ICU and cardio-oncology clinic  

A sonographer at Northwestern Memorial Hospital using the Caption Health AI to optimize ultrasound imaging.

News | Ultrasound Imaging | October 28, 2020
October 28, 2020 — Northwestern Memorial Hospital is the first hospital in the United States to purchase Caption Health...
The September-October 2020 digital edition of Diagnostic and Interventional Cardiology (DAIC) magazine. Dave Fornell is the editor. #DAIC
News | October 28, 2020
The September-October 2020 digital edition of Diagnostic and Interventional Cardiology (DAIC) magazine include links to...
Chest X-ray, posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.

Chest X-ray from a patient included in the study. Posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.

Feature | Magnetic Resonance Imaging (MRI) | October 27, 2020
October 27, 2020 – Magnetic resonance imaging (MRI) examinations can be safely performed in patients with non-MR...